Advances in the research on targets for drug discovery for Alzheimers disease supported by NSFC

Chinese Pharmacological Bulletin

Volumn 21, Issue 12, 2005, Pages 1423-1428

  Luo, Jing ^a   Wu, Lei ^b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA   (China)

Author keywords

AD targeted drugs; Alzheimers disease; Neurofibrillary tangles; NSFC; amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; CLIOQUINOL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DONEPEZIL; GALANTAMINE; RIVASTIGMINE; TACRINE;

ALZHEIMER DISEASE; CHINA; DEMENTIA; DRUG RESEARCH; DRUG TARGETING; HUMAN; NEUROFIBRILLARY TANGLE; PATHOLOGICAL ANATOMY; REVIEW;

EID: 32344445526     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Michaelis ML. Drugs targeting Alzheimers disease: some things old and some things new[J]. J Pharmacol Exp Ther, 2003, 304 (3):897-904.
2. Janus C, Pearson J, McLaurin J et al. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimers disease[J]. Nature, 2000, 408(6815):979-82.
3. Cherny RA, Atwood CS, Xilinas ME et al. Treatment with a copper-zinc chelator mark-edly and rapidly inhibits β-amyloid accumulation in Alzheimers disease transgenic mice[J]. Neuron, 2001, 30:665-76.
4. Pepys MB, Herbert J, Hutchinson WL et al. Targeted pharmacological depleting of serum amyloid P component for human amyloidosis [J]. Nature, 2002, 417:254-9.
5. Poirier J. Apolipoprotein E and Alzheimers disease. A role in amyloid catabolism[J]. Ann N Y Acad Sci, 2000, 924:81-90.
6. Wickelgen I. A wily recruiter in the battle against toxic β amyloid aggregation[J]. Science, 2004, 306:791-2.
7. Oddo S, Caccamo A, Shepherd JD et al. Triple-transgenic model of Alzheimers disease with plaques and tangles: intracellular Abeta and synaptic dysfunction[J]. Neuron, 2003, 39(3): 409-21.
8. Oddo S, Billings L, Kesslak JP et al. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome[J]. Neuron, 2004, 43(3):321-32.